Cargando…
Targeted intestinal delivery of incretin secretagogues—towards new diabetes and obesity therapies
A new strategy under development for the treatment of type 2 diabetes and obesity is to mimic some of the effects of bariatric surgery by delivering food-related stimuli to the distal gastrointestinal tract where they should enhance the release of gut hormones such as glucagon-like peptide-1 (GLP-1)...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Inc
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805852/ https://www.ncbi.nlm.nih.gov/pubmed/29412834 http://dx.doi.org/10.1016/j.peptides.2017.11.008 |